Janux Therapeutics Overview
Janux Therapeutics Discounted Cash Flow
DCF Analysis for JANX.
Get informed when a big investor buys or sells
+ FollowFair Value
$-3.77
Current Fair Value
$-3.77
↓ 127.5% Downside
Overvalued by 127.5% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison